Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

BACKGROUND: Glatiramer acetate (GA) and interferon-beta (IFN-β) are disease-modifying therapies (DMTs) for multiple sclerosis that are administered through subcutaneous (SC) or intramuscular (IM) injections. Skin reactions associated with DMTs are common and may influence patient’s health-related qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Balak, Deepak MW, Hengstman, Gerald JD, Hajdarbegovic, Enes, van den Brule, Rob JP, Hupperts, Raymond MM, Thio, Hok Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854544/
https://www.ncbi.nlm.nih.gov/pubmed/24131589
http://dx.doi.org/10.1186/1471-2377-13-146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854544/
https://www.ncbi.nlm.nih.gov/pubmed/24131589
http://dx.doi.org/10.1186/1471-2377-13-146

Ejemplares similares